IBM Maximo Application Suite 9.0 Role-Based Access Control privileges assignment
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.3 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM Maximo Application Suite 9.0. It has been rated as critical. This vulnerability affects unknown code of the component Role-Based Access Control. Performing a manipulation results in privileges assignment. This vulnerability is cataloged as CVE-2025-2898. It is possible to initiate the attack remotely. There is no exploit available. Upgrading the affected component is advised.
Details
A vulnerability classified as critical has been found in IBM Maximo Application Suite 9.0. This affects an unknown function of the component Role-Based Access Control. The manipulation with an unknown input leads to a privileges assignment vulnerability. CWE is classifying the issue as CWE-266. A product incorrectly assigns a privilege to a particular actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
IBM Maximo Application Suite 9.0 could allow an attacker with some level of access to elevate their privileges due to a security configuration vulnerability in Role-Based Access Control (RBAC) configurations.
The advisory is shared at ibm.com. This vulnerability is uniquely identified as CVE-2025-2898 since 03/28/2025. The exploitability is told to be difficult. It is possible to initiate the attack remotely. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 09/02/2025). MITRE ATT&CK project uses the attack technique T1068 for this issue.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-13597). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.5VulDB Meta Temp Score: 7.3
VulDB Base Score: 7.5
VulDB Temp Score: 7.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 7.5
CNA Vector (ibm): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Privileges assignmentCWE: CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
03/28/2025 🔍05/06/2025 🔍
05/06/2025 🔍
09/02/2025 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2025-2898 (🔍)
GCVE (CVE): GCVE-0-2025-2898
GCVE (VulDB): GCVE-100-307629
EUVD: 🔍
Entry
Created: 05/06/2025 17:35Updated: 09/02/2025 01:27
Changes: 05/06/2025 17:35 (64), 09/02/2025 01:27 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.